EP Patent

EP2124903A1 — Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent

Assigned to Takeda Pharmaceutical Co Ltd · Expires 2009-12-02 · 16y expired

What this patent protects

The present invention provides a solid pharmaceutical composition containing compound (I) having an angiotensin II receptor antagonistic action and defined in the specification and a pH control agent, which composition is superior in the stability and dissolution property of comp…

USPTO Abstract

The present invention provides a solid pharmaceutical composition containing compound (I) having an angiotensin II receptor antagonistic action and defined in the specification and a pH control agent, which composition is superior in the stability and dissolution property of compound (I).

Drugs covered by this patent

Patent Metadata

Patent number
EP2124903A1
Jurisdiction
EP
Classification
Expires
2009-12-02
Drug substance claim
No
Drug product claim
No
Assignee
Takeda Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.